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Abstract The cell cycle regulator p16 is known as a biomarker and an effector of aging.
However, its function in intervertebral disc degeneration (IVDD) is unclear. In this study, p16
expression levels were found to be positively correlated with the severity of human IVDD. In a
mouse tail suspension (TS)-induced IVDD model, lumbar intervertebral disc height index and matrix
protein expression levels were reduced significantly were largely rescued by p16 deletion. In TS
mouse discs, reactive oxygen species levels, proportions of senescent cells, and the senescence-
associated secretory phenotype (SASP) were all increased, cell cycling was delayed, and expression
was downregulated for Sirt1, superoxide dismutase 1/2, cyclin-dependent kinases 4/6,
phosphorylated retinoblastoma protein, and transcription factor E2F1/2. However, these effects
were rescued by p16 deletion. Our results demonstrate that p16 plays an important role in IVDD
pathogenesis and that its deletion attenuates IVDD by promoting cell cycle and inhibiting SASP,
cell senescence, and oxidative stress.
Introduction
Intervertebral disc degeneration (IVDD) refers to the physiological and pathological process of natu-
ral degeneration and aging of the intervertebral disc, which is the basis of various clinical spinal dis-
eases (Silagi et al., 2018). IVDD usually results in vertebral instability, disc herniation, and spinal
canal stenosis, which are commonly accompanied by low back pain with or without symptoms of
nerve root or spinal cord compression. These lead to tremendous societal and economic burdens
worldwide. It has been estimated that, at some point during their lifetime, 80–90% of the world’s
population suffer clinical low back pain, which is positively correlated with disc degeneration in
approximately 23% of these people (Smith et al., 2011; Walker, 2000).
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The human intervertebral disc is a non-vascular tissue, and its annulus fibrosus (AF) and inner layer
nucleus pulposus (NP) rely mainly on the penetration of the end plate to provide nutrition. In this
chronically high osmotic pressure, low pH, hypoxic and low-nutrition environment, the cells are less
active. This is one of the reasons for the poor self-healing ability of the disc’s structure and function
after tissue damage, and thus, intervertebral discs degenerate more easily than other tissues in the
body (Feng et al., 2016). Among the many factors that cause intervertebral disc degeneration is the
accumulation of senescent disc cells (most of which are NP cells), which has provided a novel insight
into IVDD pathogenesis. Senescent NP cells generate only a small number of new cells; therefore,
the number of functional cells decreases gradually. Moreover, senescent NP cells may change the
disc microenvironment, creating a senescence-associated phenotype in which proinflammatory fac-
tors are overexpressed, extracellular matrix (ECM) is decreased, and growth factors and chemokines
are downregulated (Le Maitre et al., 2007; Markova et al., 2013; van Deursen, 2014). However,
the molecular mechanisms that underpin cell senescence in IVDD are unclear.
Cell senescence is regulated by various molecular signaling pathways. One of the canonical mole-
cules involved in cell senescence is p16 (p16INK4a), which is encoded by the CDKN2A gene and
belongs to the cell cycle regulatory pathway (Serrano, 1997). Senescent cells, most of which seem
to express p16 (Childs et al., 2017), accumulate with aging and are conducive to tissue
dysfunction. The clearance of p16-positive senescent cells in adipose tissue, skeletal muscle and
the eye has been suggested to delay aging-associated disorders in mice (Baker et al., 2011). Specif-
ically, the systemic clearance of p16-positive senescent cells and conditional Cdkn2a gene deletion
have been shown to mitigate age-associated IVDD in mice, mostly by suppressing the senescence-
associated secretory phenotype (SASP), improving matrix homeostasis, and reducing apoptosis
(Novais et al., 2019; Patil et al., 2019). However, we do not yet know how p16 drives disc cell
senescence and whether other factors are present in the progression of IVDD, especially in human
discs.
Increasing levels of reactive oxygen species (ROS), another main feature of aging, are involved in
a number of age-related pathologies. Senescence can occur under prolonged oxidative states; and
thus, ROS is seen as an important mediator of the progression of cellular senescence (Colavitti and
Finkel, 2005). Pathological ROS levels have been implicated in the induction of senescence-like phe-
notypes similar to that of p16-induced senescence. An increasing number of studies have shown that
eLife digest Neck and shoulder pain, lower back pain and leg numbness are conditions that
many people will encounter as years go by. This is because intervertebral discs, the padding
structures that fit between the bones in the spine, degenerate with age: their cells enter a
‘senescent’, inactive state, and stop multiplying.
A protein known as p16, an important regulator of cell growth and division, is known to
accumulate in senescent cells. In fact, in mouse fat tissue, muscles or eyes, removing the cells that
contain high levels of p16 delays aging-associated disorders. However, it was still unknown whether
deactivating the gene that codes p16 in senescent cells could delay disc degeneration.
Here, Che, Li et al. discovered that p16 is highly present in the senescent cells of severely
degenerated human intervertebral discs. The cells in the nucleus pulposus, the jelly-like and most
critical tissue in the intervertebral discs, were extracted and grown in the lab under conditions that
replicate the early stages of damage to the spine. Drugs and genetic manipulations were then used
to decrease the amount of p16 in these cells.
The experiments showed that reducing the levels of p16 results in the senescent cells multiplying
more and showing fewer signs of damage and aging. In addition, the discs of mice in which the
gene that codes for p16 had been deleted were less prone to degeneration compared to ‘normal’
mice in similar conditions.
Overall, the work by Che, Li et al. shows that inhibiting p16 in disc cells delays the aging process
and reduces the degeneration of intervertebral discs. These findings may one day be applicable to
people with intervertebral disc diseases who, for example, could potentially benefit from a gene
therapy targeting the cells which produce p16.
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p16 might play a role in oxidative stress-associated senescence (Gonçalves et al., 2016; Mas-
Bargues et al., 2017). Nonetheless, whether p16 contributes to intervertebral disc aging by increas-
ing ROS is unclear. The present study aimed to highlight the influence of p16 on disc degeneration,
mainly focusing on oxidative stress and human NP cell proliferation, and verified this effect in mice
that have homozygous deletion of Cdkn2a.
Results
p16 was upregulated in the NP of degenerated human intervertebral
discs
To explore the role of p16 in IVDD, p16 expression was first verified in the NP tissues of patients
with various degrees of disc degeneration, as examined by histological staining (Pfirrmann grades 2–
5, Figure 1—figure supplement 1). H and E staining showed a substantially disordered tissue tex-
ture in samples with a high Pfirrmann grade, in which hypertrophic and vacuole-like cells and multi-
nuclear giant cells were present at the end of the sample (Figure 1A). Masson and Safranin O
staining showed smaller amounts of proteoglycans (PGs) and increased levels of fibrosis in NP tissues
that had a high Pfirrmann grade (Figure 1A). These results confirm that severely degenerated NP tis-
sue is correlated with a high Pfirrmann grade. In addition, immunohistochemistry (IHC) and western
blotting (WB) revealed that degenerated discs with a higher Pfirrmann grade expressed a higher
level of p16 than those with a lower Pfirrmann grade (Figure 1B,C,D; with p16 expression levels and
their corresponding Pffirmann grades being shown in Figure 1—figure supplement 2). These results
confirm that p16 accumulates in NP tissues as IVDD progresses.
p16 regulated NP cell proliferation and senescence under IL-1b
stimulation by mediating oxidative stress and the cell cycle
To uncover how p16 participates in IVDD progression, NP cells with mild degeneration were iso-
lated from Pfirrmann grade 2 tissues and cultured in vitro. IL-1b was used to induce NP cell
degeneration. Immunofluorescent (IF) and SA-b-gal staining clearly illustrated that IL-1b greatly
increased the percentage of senescent NP cells and p16 protein expression when compared
with control levels (Figure 2A,D,E). In addition, the effect of altering p16 expression levels on
NP cell degeneration and proliferation was investigated. p16 expression was down- and upregu-
lated by siRNA or plasmid transfection, respectively. The transfection efficiencies of targeted
siRNAs and plasmids, compared with those of null siRNA and empty plasmid, respectively, are
presented in Figure 2—figure supplement 1. p16 expression decreased after siRNA-mediated
knockdown, which decreased the proportion of NP cells that demonstrated a senescent pheno-
type. By contrast, p16 overexpression caused a marked opposite effect (Figure 2B,H). In addi-
tion to the degree of aging, proliferative ability is another indicator of cellular degeneration. Cell
counting kit-8 (CCK-8) analyses confirmed that NP cell proliferation was reduced by p16 overex-
pression and promoted by p16 knockdown when compared with the levels seen after treatment
with IL-1b treatment alone (Figure 2C).
To determine the potential mechanism by which p16 modulates NP cell physiological behavior,
flow cytometry was used to analyze ROS levels and the cell cycle. ROS levels were obviously higher
when p16 expression was increased (Figure 2F,G). As p16 expression gradually increased from the
p16+IL-1b group to the IL-1b group and the control group, the cells presented cell-cycle arrest in
the G0/G1 phase. Interestingly, considerably more NP cells progressed through G0/G1 to S phase fol-
lowing p16 downregulation (Figure 2F,I). These results demonstrate that p16 might regulate senes-
cence by mediating oxidative stress and promoting proliferation by accelerating the movement of
cells through the G1/S checkpoint.
Rapamycin inhibited p16 expression and promoted NP cell proliferation
by reducing oxidative stress and mediating the cell cycle
Recent studies have reported that rapamycin prevents IVDD by inhibiting cell senescence via the
mTOR signaling pathway (Choi et al., 2016; Ito et al., 2017). Therefore, the application of rapamy-
cin was used to inhibit cell senescence in order to explore the interplay between this cellular event
and p16 in IVDD prevention. Rapamycin antagonized the effect of IL-1b, decreasing p16 expression
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Figure 1. p16 expression in NP cells from human interverbal discs with different degrees of degeneration (G2–G5 groups according to Pfirrmann
grade). (A) Representative images of H and E staining showing cell/tissue general morphology. Safranin O staining with collagen and NP cells
appearing orange and fibers blue/violet. Masson staining with collagen and NP cells appearing blue and fibers red; and immunohistochemical staining
Figure 1 continued on next page
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and the percentage of senescent NP cells (Figure 3A,B,C,E,F). Flow cytometry analyses revealed
significantly lower ROS levels in the IL-1b+rapamycin group than in the IL-1b-alone group, and
showed that rapamycin treatment reduced the ratio of cells in the G0/G1 phase; meanwhile, the ratio
of cells in S phase was higher after rapamycin treatment (Figure 3D,G,H). CCK-8 assays also showed
a higher level of proliferation in the IL-1b+rapamycin group when compared with the IL-1b alone
group (Figure 3I). These changes parallel the above described impact of p16 siRNA. These findings
demonstrate that rapamycin can prevent NP cell degeneration by reducing ROS levels and mediat-
ing the cell cycle, which might be associated with p16 inhibition.
p16 deletion partly postponed mouse IVDD
To further assess whether p16 deletion plays a positive role in IVDD prevention in vivo, the Cdkn2a
gene knock out (p16 KO) mice and the tail suspension (TS) method were used to establish a mouse
IVDD model. After 4 weeks of TS, muscles around the spine were congested with varying degrees of
injury (Figure 4—figure supplement 1B). Based on the morphological and histological changes
among different groups, disc height index (DHI) analyses showed that mouse disc heights were
decreased by TS but were maintained in p16 KO mice when compared with WT mice (Figure 4A,C).
Furthermore, micro-magnetic resonance imaging (MRI) demonstrated that TS reduced water content
in the disc and that p16 deletion significantly protected against this effect (Figure 4H, Figure 4—fig-
ure supplements 2, 3). After TS, disc heights decreased and more vesicular cells appeared, and
the discs in p16 KO mice exhibited obviously higher glycosaminoglycan (GAG) levels with or without
TS than those in WT mice (Figure 4B).
Inflammation is a vital part of the disc degeneration process. To examine the effects of systemic
p16 knockout, the levels of inflammatory factors in the NP tissues of mice were analyzed. There was
a clear difference in inflammation between p16 KO and WT mice, as p16 deletion reduced the
expression of TNF-a, IL-1b, and IL-6 (Figure 4G). These results were confirmed when RNA expres-
sion was assessed (Figure 4F). Furthermore, because NF-kB-p65 has a vital function in regulating
inflammatory responses and is activated by various stimuli, including stress, we conducted analyses
on NF-kB-p65 expression levels. Western blot analyses showed higher p65 levels in the TS group
than in the control group. After p16 gene deletion, p65 expression decreased significantly
(Figure 4D,E).
Matrix metallopeptidases (MMPs) can degrade all types of ECM proteins,
decreasing the aggrecan and collagen II content of the tissue. Thus, we evaluated MMP3, MMP9,
MMP10, and MMP13 mRNA and protein expression levels. The levels of these MMPs mostly
increased after TS, and p16 deletion partly reversed these changes (Figure 4D,E). Treatment effects
on the expression levels of the typical components of ECM, aggrecan, collagen I, collagen II, and
collagen X, were measured by western blot or qRT-PCR. Aggrecan and collagen II, which are protec-
tive ECM components, were slightly degraded in p16 KO mice compared to WT
mice; whereas collagens I and X, which are harmful ECM components, were expressed at low levels
in p16 KO mice (Figure 4D,E). In summary, these results suggest that p16 deletion partly postpones
IVDD in mice as assessed in terms of changes in disc height, water content, inflammation, and ECM
components.
Figure 1 continued
for p16. (B) Quantification of p16-positive cells (%). p16 protein levels were assessed by (C) western blotting and (D) measured by densitometric
analyses and expressed as folds relative to grade 2 (G2) NP samples. Data are presented as mean ± SD (n = 3); *p<0.05; **p<0.01.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Source data and related summary statistics for Figure 1A and C.
Figure supplement 1. Representative magnetic resonance imaging (MRI) scans of patients with different categories of disc degeneration according to
Pfirrmann grade.
Figure supplement 2. Pffirmann grade of the degenerated disc from the human specimens correlates individually with p16 expression. ***p<0.001.
Figure supplement 2—source data 1. Related summary statistics.
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Figure 2. Effect of p16 on senescence, reactive oxygen species (ROS) levels and NP cell proliferation upon IL-1b stimulation (10 ng/mL). Human NP
cells were grouped as follows: normal cultured cells (control), IL-1b treated cells (IL-1b), p16-siRNA-transfected cells treated with IL-1b (IL-1b+siRNA),
and p16 plasmid-transfected cells treated with IL-1b (IL-1b+p16). (A) Representative immunofluorescent micrographs stained for p16. (B) p16 protein
levels as assessed by western blotting. (C) Cell proliferation as assessed by CCK-8 assays. (D) SA-b-gal staining. (E) Total p16-positive and b-gal-positive
cells (%). (F) ROS levels and the cell-cycle distribution of freshly collected human NP cells as determined by flow cytometry. (G) Quantitation of ROS
levels. (H) p16 level measured by densitometric analysis and expressed relative to the control. (I) Cell-cycle distribution. Data are presented as
mean ± SD (n = 3); *p<0.05; **p<0.01; ***p<0.001.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Source data and related summary statistics for Figure 2B, C, D and F.
Figure supplement 1. Efficiency of transfection with p16 siRNA and the p16 plasmid compared with that with null siRNA and empty plasmid.
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Figure 3. Effect of rapamycin (50 nM) on senescence, reactive oxygen species (ROS) levels and NP cell proliferation upon IL-1b stimulation (10 ng/mL).
Human NP cells were grouped as follows: normal cultured cells (control), IL-1b treated cells (IL-1b), and rapamycin-stimulated cells treated with IL-1b (IL-
1b+rapa). (A) Representative immunofluorescent micrographs stained for p16. p16 protein levels as (B) assessed by western blotting and (C) measured
by densitometric analysis, with results expressed relative to the control. (D) Quantitation of ROS levels. (E) SA-b-gal staining. (F) Total p16-positive and
b-gal-positive cells (%). (G) ROS levels and the cell-cycle distribution of freshly collected human NP cells as determined by flow cytometry. (H) Cell-cycle
distribution. (I) Cell proliferation as assessed by CCK-8 assays. Data are presented as mean ± SD (n = 3). *p<0.05; **p<0.01; ***p<0.001.
The online version of this article includes the following source data for figure 3:
Source data 1. Source data and related summary statistics Figure 3B, E, G and I.
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Figure 4. p16 deletion delayed mouse intervertebral disc degeneration (IVDD). WT and p16 KO mice were fed on the ground or with tail suspension
(TS). (A) Radiographs of overall mouse length. (B) After H and E staining and Safranin O staining, collagen and NP cells are orange, and fibers are blue.
(C) The intervertebral disc height index as calculated on the basis of lumbar vertebrae. (D) Associated protein levels as assessed by western blotting
and (E) as measured by densitometric analysis, with results expressed relative to those in WT mice. (F) Target mRNA expression assessed by RT-PCR
Figure 4 continued on next page
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p16 deletion exerted an antioxidant effect and affected progression
from G1 to S phase in vivo
To further determine the potential mechanism by which p16 functions in IVDD in vivo, multiple bio-
logical indicators were explored. Specifically, we assessed the degree of senescence, proliferative
capacity, oxidative stress level, and the expression of cell-cycle proteins in p16 KO and WT mice
with or without TS. IHC analyses of b-gal and western blot of p19 and p53 revealed that the discs of
WT mice exhibited a more senescent phenotype than those of p16–/– mice in both the TS and con-
trol groups (Figure 5A,C,D,F). The proportions of PCNA- and Ki67-positive cells, the percentages of
proliferative cells, and the IGF1 protein levels in the discs were substantially higher in p16 KO mice
than in WT mice, even after TS (Figure 5A). Interestingly, the levels of vascular endothelial growth
factor (VEGF), a microangiogenesis marker, were decreased in p16 KO mice, suggesting a protective
function of p16 in disc degeneration (Figure 5C,D).
Because ROS levels decreased in human NP cells upon silencing p16, as described above, the
antioxidant enzyme gene expression and ROS levels were determined in mouse disc tissues. SOD1,
SOD2, GPX1, GPX3, and CAT mRNA expression increased upon p16 deletion, and p16 KO mice
had lower total ROS levels than did WT mice, even after TS (Figure 5B,G,I). The mouse IVDD model
also revealed the same effects on Sirt1, SOD1, and SOD2 protein levels (Figure 5C,D). The DNA
injury marker 8-hydroxy-deoxyguanosine (8-OHdG) can be induced by oxidative stress.
When compared to WT mice, the proportions of 8-OHdG-positive cells were greatly decreased in
p16 KO mice, indicating that p16 deletion plays a protective role in the antioxidant process in the
disc (Figure 5A).
To explore whether p16 affects proliferation by mediating the cell cycle, cell-cycle progression
and cell-cycle-related proteins were analyzed by flow cytometry and western blotting. p16 KO mice
showed increased progression of cells from G0/G1 into S phase compared with WT mice, with or
without TS (Figure 5B,H). CDK4, CDK6, pRb, E2F1 and E2F2 protein expression levels were upregu-
lated in p16 KO mice compared to WT mice. Conversely, the expression level of RB protein was
downregulated in p16 KO mice (Figure 5C,E). These results demonstrate that p16 deletion
can partially inhibit aging-related senescence by reducing disc oxidative stress injury and enhancing
NP cell proliferation by promoting progression through the G1/S checkpoint.
NF-kB-p65 promoted p16 expression in human NP cells by activating
the p16 promoter
Because expression of the transcription factor NF-kB-p65 differed between p16 KO and WT
mice, it was hypothesized that NF-kB-p65 might control p16 protein levels. To confirm that NF-
kB-p65 controls p16 at the transcriptional level, five putative NF-kB-p65 binding sites in the
CDKN2A promoter region were identified and chromatin immunoprecipitation (ChIP) primers
were designed using Primer Premier (Supplementary file 1). First, when we assessed whether
NF-kB-p65 binds to the five putative promoter sequences, only two sites were verified
by ChIP as efficient binding sites. One putative promoter sequence that was bound effectively is
shown in Figure 6A, and another promoter sequence with no binding is shown in Figure 6—fig-
ure supplement 1. Using human genomic DNA as a template, the whole CDKN2A promoter
Figure 4 continued
relative to GAPDH expression. (G) IL-1b, IL-6 and TNF-a levels in disc tissues as determined by ELISA. (H) The modified Thompson classification as
assessed on the basis of lumbar disc signals. (I) Safranin O-positive area (%). Data are presented as mean ± SD (n = 3); *p<0.05; **p<0.01; ***p<0.001.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Source data and related summary statistics for Figure 4B, C, D, G and H.
Figure supplement 1. Establishment of TS-induced mouse IVDD model.
Figure supplement 2. Representative micro-MRI of mouse intervertebral discs.
Figure supplement 3. Pffirmann grade of degenerated disc from the mice specimens.
Figure supplement 3—source data 1. Related summary statistics.
Figure supplement 4. The intervertebral disc height index (DHI) was calculated by averaging the measurements obtained from the (A) posterior, (B)
middle, and (C) anterior portions of the intervertebral disc and dividing these values by the average height of the adjacent (D–I) posterior, middle, and
anterior portions of the vertebral body.
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Figure 5. p16 deletion exerted an antioxidant effect and promoted mouse NP cell proliferation in vivo. WT and p16 KO mice were fed on the ground
or with tail suspension (TS). (A) Representative micrographs of slices stained immunohistochemically for 8-hydroxy-2 deoxyguanosine (8-OHdG),
senescence-associated b-galactosidase (SA-b-gal), Ki67 and proliferating cell nuclear antigen (PCNA). (B) Reactive oxygen species (ROS) levels, cell
proliferation (PRL) and cell-cycle distribution in freshly collected mouse NP cells, as measured by flow cytometry. (C) Associated protein levels were
Figure 5 continued on next page
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segment was amplified by PCR (lane 1 of Figure 6A). Clear DNA amplification was examined
after immunoprecipitation without the irrelevant control IgG (lane 2 of Figure 6A), and with the
anti-p65 antibody (lane 3 of Figure 6A).
Next, the WT and binding-site mutant CDKN2A promoter sequences were cloned into the
pGL4.23-basic vector (producing pGL4.23-wt and pGL4.23-mut, respectively), and the resulting plas-
mids were transiently transfected into human NP cells (Figure 6B). Transfection with the empty
plasmid (pGL4.23) without the CDKN2A promoter sequence and the Renilla expression plasmid (vec-
tor+pGL+pRL) or with the p65 plasmid, and pGL4.23 without the CDKN2A promoter sequence and
the Renilla expression plasmid (p65+pGL+pRL) served as the negative controls. Luciferase activity
was significantly higher in NP cells transfected with the p65 and pGL-wt plasmids than in those trans-
fected with empty plasmid and the pGL-wt plasmid, indicating that p65 successfully activated the
CDKN2A promoter. By contrast, luciferase activity was significantly lower in NP cells transfected with
the p65 and pGL-mut plasmids than in those transfected with the p65 and pGL-wt plasmids
(Figure 6C). The findings confirm that the CDKN2A promoter region with the predicted NF-kB-p65
binding sites is sufficient to promote transcription, providing a molecular mechanism
that emphasizes p65-dependent p16 transcriptional activation in NP cells.
Discussion
Although numerous studies have proven that p16 contributes to IVDD pathogenesis, few have
focused on the role of p16 in humans. Here, an unbiased comparison of p16 expression in NP cells
from IVDD patients with varying Pfirrmann scores showed that p16 expression is positively correlated
with the degree of human disc degeneration. Along with the increase in the severity of human IVDD,
NP cells showed decreased PG contents, increased fibrosis, and greater vacuolization; moreover,
more multinucleated giant cells were observed, and p16 accumulated. The findings show that p16
plays a role in IVDD progression. Using NP cells harvested from patients with disc degeneration with
a Pfirrmann score of 2 (mild disc degeneration), in-vitro studies further explored the function of p16
in the pathology of disc degeneration. The results suggest that p16 deficiency decreases oxidative
stress and DNA damage in NP cells and contributes to NP cell proliferation, which protects against
IVDD by promoting cell-cycle progression. In addition, for potential therapeutic exploration, these
findings have provided theoretical and experimental evidence to support the potential use of rapa-
mycin or the upstream approach targeting NF-kB-p65 to suppress p16 expression. Thus, the current
investigation has not only demonstrated the different mechanisms of p16 in IVDD but also may pro-
vide theoretical evidence to inform the exploration of effective methods to downregulate p16
in order to reverse IVDD.
Although the presence of p16-positive cells indicates that an organism is in an inactive state
(Baker et al., 2011), it is unclear whether the differential expression of p16 affects human disc
degeneration. To simulate the microenvironment in disc degeneration, IL-1b was used to induce NP
cell senescence. Multiple analyses revealed that p16 expression increased significantly as the degree
of senescence increased in NP cells. However, the senescent phenotype of NP cells became less pro-
nounced when p16 was silenced. By contrast, increased NP cell senescence was observed when p16
levels were upregulated by plasmid transfection. These results imply that p16 not only is produced
by NP cell senescence but also accelerates NP cell senescence.
ROSs are mainly induced during cellular aging, but the mechanism by how p16 regulates ROS lev-
els in NP cells is not yet clear. The ROS levels in different groups of NP cells expressing different lev-
els of p16 showed that ROS levels increased along with p16 overexpression. This result suggests a
strategy to reduce ROS in NP cells via p16 suppression.
Figure 5 continued
assessed by western blotting and (D, E) measured by densitometric analysis with results expressed relative to those in WT mice. (F) Percentage of total
immuno-positive cells (%). (G) Target mRNA expression as assessed by RT-PCR relative to GAPDH expression. (H) Cell-cycle distribution. (I) ROS and
PRL (%) quantitation. Data are presented with mean ± SD (n = 3); *p<0.05, **p<0.01, ***p<0.001.
The online version of this article includes the following source data for figure 5:
Source data 1. Source data and related summary statistics for Figure 5A, B and C.
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Figure 6. NF-kB-p65 bound the CDKN2A gene promoter and promoted p16 expression in human NP cells. (A)
CDKN2A promoter sequences were recovered by PCR from p65 immunoprecipitates. (B) p65-like elements in the
human CDKN2A promoter region and the mutated sequence are marked in red (upper panels). Below: structural
schematic of the WT and mutant pGL4.23-p16 promoter reporter plasmids. (C) Luciferase activity driven by the
CDKN2A promoter was more pronounced following NF-kB treatment. By contrast, luciferase activity that was not
driven by the CDKN2A luciferase reporter decreased in the absence of NF-kB, and luciferase activity not driven by
the mutant CDKN2A luciferase reporter decreased upon NF-kB treatment. Data are shown with mean ± SD
(n = 3); ***p<0.001.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Source data and related summary statistics for Figure 6C.
Figure supplement 1. Another site in NF-kB-p65 that is predicted to bind the CDKN2A promoter.
Figure supplement 1—source data 1. Source data and related summary statistics for Figure 6—figure supple-
ment 1C.
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Senescence plays a basic role in regulating cell cycling by halting cell proliferation, and p16
expression was observed to be negatively correlated with human NP cell proliferation, an effect that
was reversed by p16 downregulation. Previously, p16 was shown to be a cyclin-dependent kinase
(CDK) inhibitor that is sufficient to inhibit cell proliferation and to induce aging features in mammals
by restraining the cell cycle (Boquoi et al., 2015). The in-vitro model illustrated that p16 can inhibit
the progression of NP cells from G1 to S phase, which is an essential mechanism by which prolifera-
tion is regulated in human NP cells.
On the basis of the results described above, it is more feasible to suppress p16 expression using
a specific drug rather than siRNA transfection. After all, for patients, drug therapy is more conve-
nient and economical than gene therapy. Rapamycin was previously shown to have antiaging effects
in multiple cells and organisms by modulating oxidative stress, nutrient sensing, and the cell cycle
(Richardson, 2013; Wang et al., 2017a). Rapamycin was also shown to inhibit p16 expression to
some extent (Gidfar et al., 2017). However, previous studies on the effect of rapamycin on disc
degeneration focused on the role of this compound in autophagy (Ito et al., 2017; Tu et al., 2018).
Therefore, rapamycin was applied to inhibit p16 and to explore its function in regulating ROS levels
and the cell cycle. Rapamycin significantly decreased p16 expression and reversed the senescent
phenotype of human NP cells. Furthermore, rapamycin decreased ROS levels in NP cells, which
showed increased proliferation. Cell-cycle analyses indicated that rapamycin promoted the progres-
sion of NP cells from G1 to S phase. Therefore, rapamycin may suppress ROS levels and promote NP
cell proliferation, and these effects may be related to its ability to suppress p16. Taken together,
p16 downregulation is likely to exert an antioxidant effect and promotes human NP cell proliferation,
therefore playing a protective role in IVDD.
Figure 7. A proposed model for the mechanism of p16 in regulating intervertebral disc degeneration (IVDD). NF-kB-p65 activates p16 expression. p16
deficiency alleviates the reactive oxygen species (ROS) levels, senescence-associated secretory phenotype (SASP) and cellular senescence.
Subsequently, p16 deficiency promotes the activity of cellular antioxidation, and the proliferation and stability of ECM, like aggrecan and collagen II. All
of the pathways ultimately protect against the development of IVDD.
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To verify these results in vivo, compound mutant mice with homozygous Cdkn2a deletion were
used to establish an IVDD model involving TS. As a shock absorber for the spine, the basic role of
the disc is a mechanical one containing load distribution, energy dissipation, and motion permit in
daily activities. Mechanical factors have been proposed as one of the mechanisms necessary for
accelerating the aging progression of both human and rodent discs via altered loading in several
studies, so the TS mice model is an applicable mechanical representation of both tensile force on
human discs and the aging process (Hutton et al., 2002). Simulation of weightlessness by TS
changes flexion-extension, axial rotation, lateral bending and hydrostatic pressure in the disc and
leads to destruction of the ECM destruction, an inflammatory response and a catabolic process
that represents premature aging-related IVDD progression (Földes et al., 1996).
In the present study, p16 deletion protected against changes in disc heights and disc water con-
tents in mice, which are the most intuitive indicators of IVDD in the clinic. Levels of aggrecan and col-
lagen II, which protect NP cells in the ECM, were significantly increased in p16 KO mice with or
without TS. By contrast, the protein levels of the fibrosis markers collagens I and X decreased after
p16 deletion. To demonstrate whether p16 deletion affects inflammation in mouse discs, some
inflammatory factors were further examined, and the results showed that p16 deletion reduced both
the protein and the mRNA levels of the inflammatory factors. Encouragingly, the measurements of
ROS levels and antioxidant activity showed that p16 deletion improved antioxidant activity in the
discs and decreased ROS levels and DNA injury. Furthermore, examinations of the proliferation
markers Ki67, PCNA, and IGF-1 indicated increased proliferative capacity in NP cells after p16 dele-
tion. Interestingly, angiogenesis, which has been shown to increase the risk of IVDD (Kwon et al.,
2017; Zaidi et al., 2018), was reduced in p16 KO mice compared with WT mice; this might be a
novel direction for future research. Finally, the analyses of the cell cycle and cell cycle-related pro-
teins confirmed that p16 suppression activates CDK4 and CDK6 to promote Rb protein phosphoryla-
tion, enhance E2F1/E2F2 activity, and promote the progression of NP cells from G1 to S phase.
Taken together, these findings demonstrate that ablation of p16 can relieve mouse disc degenera-
tion by protecting the ECM, inhibiting fibrosis, reducing inflammation, decreasing ROS levels, and
promoting proliferation by regulating the cell cycle.
As p16 plays an important role in IVDD, it is essential to understand the molecular mechanism
of p16 activation and dysfunction. Previous studies have shown that Bmi-1 and
1,25-dihydroxyvitamin D inactivate p16 (Chen et al., 2019; Taylor et al., 2015;
Yamakoshi et al., 2015). However, the molecular mechanism of p16 activation is still unclear.
Bmi-1 is reported to active NF-kB signaling in glioma angiogenesis, cell migration and invasion
(Jiang et al., 2013; Sun et al., 2014). By contrast, 1,25-dihydroxyvitamin D takes part in the
suppression of inflammation and anticancer properties by blocking NF-kB activation (Chen et al.,
2011; Fekrmandi et al., 2015). Intriguingly, a decreased NF-kB-p65 level was observed in the
discs of p16 KO mice compared with those of the WT. Therefore, further work is necessary to
explore the relation between NF-kB-p65 and p16 in disc tissue. NF-kB-p65 is well known for its
role in regulating inflammation, immune response, cell division and apoptosis, and has been
shown to participate in IVDD progression (Wang et al., 2018; Wang et al., 2017b). The present
results support the observation that NF-kB-p65 is involved in p16 activation. Furthermore, by
conducting analyses with the JASPAR database of transcription factor binding profiles, five puta-
tive NF-kB-p65 binding sites were identified in the CDKN2A promoter, and the ChIP assays
have confirmed the activity of two of these putative binding sites. Finally, these two binding
sites were tested in luciferase reporter gene assays, which showed that NF-kB-p65 bound at one
binding site in the CDKN2A promoter, confirming that NF-kB-p65 is upstream of p16.
Taken together, from the data in the current study, a model illustrating the role and possible
mechanisms of p16 in regulating IVDD can be proposed (Figure 7). NF-kB-p65 probably
increases p16 expression by promoter activation. p16 deficiency regulates the antioxidative
behaviors of NP cells, resulting in the suppression of ROS levels and the alleviation of both NP
cellular senescence and the SASP. Subsequently, p16 deficiency promotes cellular proliferation
and the production of ECM, such as collagen II and aggrecan. It can be speculated that molecu-
lar studies of the p16 in the development of IVDD may provide new solutions for preventing
degenerative disc diseases.
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Human NP collection
Thirty-two fresh human intervertebral disc tissue samples were harvested from patients undergoing
intervertebral disc surgery at the First Affiliated Hospital of Nanjing Medical University (patients’
information is listed in Supplementary file 2). Before the operation, the informed consents of the
patients were obtained. These consents included the voluntary donation of the diseased nucleus pul-
posus tissue extracted from the operations, and consent for the use of all specimens for scientific
research and for publication of the results obtained in scientific journals. This project was imple-
mented by the approval of the Ethics Committee of the First Affiliated Hospital of Nanjing Medical
University (registered number 2018 SR-233). All the samples were divided into four groups using the
Pfirrmann score, which was determined on the basis of MRI results from each patient before surgery.
Human NP cell isolation and culture
The NP tissues were cut into small pieces and digested at 37˚C overnight with collagenase XI (Sigma,
Ohio, USA), dispase II (Sigma, Ohio, USA) and cell culture medium (containing 2% penicillin/
streptomycin and 10% fetal bovine serum, Thermo, Massachusetts, USA). The cell solution was cen-
trifuged to obtain the cell pellets. NP cells were stimulated with 10 ng/mL IL-1b (Sigma, Ohio, USA)
to establish a degeneration model (Shen et al., 2017). We also cotreated IL-1b-treated NP cells with
50 nM rapamycin (Gao et al., 2018) (Sigma, Ohio, USA) to determine its function during NP cell
degeneration.
Plasmid transfection and siRNA interference
Human p16 plasmid vectors and siRNA were provided by Invitrogen (Massachusetts, USA) and Gen-
ePharma (Shanghai, China). The CDKN2A gene was inserted into the pcDNA3.1 plasmid. On the
basis of the manufacturer’s instructions, NP cells were transfected with Lipo6000 (Beyotime, Shang-
hai, China). Then cells were transfected by siRNA against CDKN2A (Lau et al., 2007). 24 hr later, IL-
1b (10 ng/mL) was used to treat the cells for 4 days, and the cells were harvested for subsequent
experiments. The transfection efficiency was examined by quantitative real-time polymerase chain
reaction (qRT-PCR), immunofluorescence (IF), and western blot (WB).
p16 KO mice and tail suspension (TS) IVDD model
The Cdkn2a heterozygous mice (FVB N2 background) were a gift from Baojie Li (Shanghai Jiao Tong
University, Shanghai, China) and had been backcrossed on the C57BL/6J background. These mice
were mated to produce Cdkn2a knock-out (p16 KO) and wild-type (WT) littermates. Animal use was
approved by the Institutional Animal Care and Use Committee of Nanjing Medical University
(approval number: IACUC-1709021). As an IVDD model (Hutton et al., 2002; Nakamura et al.,
2013), TS was carried out in mice for 4 weeks. A specialized cage was made to suspend the mice
(Figure 4—figure supplement 1A). Forty-eight 16-week-old WT and p16 KO mice were randomly
separated into two groups that were divided into two subgroups: WT control (WT), p16 KO control
(p16 KO), tail-suspended WT (WT+TS), and tail-suspended p16 KO (p16 KO+TS) groups. At the
appropriate time point, the mice were humanely killed, and the lumbar vertebrae (from lumbar 1 to
5) were removed for examination.
Immunofluorescence
Cultured NP cells were rinsed three times using phosphate-buffered saline (PBS), fixed by 4% formal-
dehyde for 15 min, incubated in 0.25% Triton X-100 for 15 min, and blocked by 5% bovine serum
albumin (BSA, Sigma, Ohio, USA) in PBS for 30 min at room temperature. Then, the cells were
treated with primary antibody against p16 (ab51243, Abcam, Cambridge, UK) for one night at 4˚C,
and incubated with DyLight 488-conjugated goat anti-rabbit IgG antibody (Abbkine, California,
USA) for 2 hr in the dark at room temperature. The cells were visualized using a fluorescence micro-
scope (Leica, Wetzlar, Germany), and nuclei were counterstained with DAPI (Beyotime, Shanghai,
China).
Radiological study
Before the animals were sacrificed, X-ray images and micro-MRI scans were taken. X-rays were used
to measure the disc height and vertebral body. The intervertebral disc height index (DHI) was
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obtained by calculating the average values of the posterior, middle and anterior parts of the inter-
vertebral disc, and these values were divided by the average height of the adjacent vertebral body
(Figure 4—figure supplement 4). Micro-MRI was performed using T2-weighted sections. On the
basis of changes in signal intensity with four grades (1, normal; 2, minimal decrease; 3, moderate
decrease; and 4, severe decrease), a revised Thompson classification was used to evaluate disc
status.
Histological staining
Mouse lumbar spines (L3–L6) were decalcified for 14 days after fixation in 4% paraformaldehyde
(PFA) solution. Human NP tissues and mouse spines were processed for paraffin embedding and
sectioning into 5-mm-thick slices for histological staining or immunohistochemistry (IHC), as
described below. To evaluate disc degeneration, deparaffinization, hydration, and hematoxylin and
eosin (H and E) staining were used to treat the paraffinized slices (Wang et al., 2009) so that cells
and tissue morphology could be observed. Masson’s stain (Nagatoya et al., 2002) was added to
analyze NP fibrosis; Safranin O (Kiviranta et al., 1985) was added to analyze proteoglycans (PGs);
and senescence-associated beta-galactosidase (SA-b-gal) (Ji et al., 2012) was added to identify
senescent cells.
IHC
IHC was performed as in a previous study (Yukata et al., 2018). Briefly, sections were treated with
sodium citrate (10 mM, 100˚C) (for antigen retrieval) and H2O2 (10% in PBS) (for endogenous peroxi-
dase inactivation). Next, the slices were blocked with 10% goat serum, and incubated overnight at 4˚
C using primary antibodies against b-galactosidase (ab203749, Abcam, Cambridge, UK), 8-hydroxy-
2 deoxyguanosine (8-OHdG) (ab48508, Abcam, Cambridge, UK), Ki67 (ab15580, Abcam, Cam-
bridge, UK), and PCNA (ab92552, Abcam, Cambridge, UK). Then, biotinylated goat anti-mouse or
anti-rabbit IgG (Sigma, Ohio, USA) were used to treat the slices, before they were incubated with
Vectastain Elite ABC reagent (Fisher Scientific, Hampton, New Hampshire, USA) for 30 min.
3,3-diaminobenzidine was used for staining, followed by counterstaining with hematoxylin. 8-OHdG,
Ki67, and PCNA are mostly expressed in the nucleus; p16 and b-galactosidase are expressed in both
the nucleus and the cytoplasm. The positive cell rate for 8-OHdG, Ki67 and PCNA is the ratio of the
number of positive nuclei to the number of all hematoxylin-labeled cells. The positive cell rate for
p16 and b-galactosidase is the ratio of the number of positive nuclei or/and cytoplasm to the num-
ber of all hematoxylin-labeled cells.
Protein extraction and western blot (WB)
Proteins were harvested from human NP tissues or mouse disc tissues with a Protein Extraction Kit
(Thermo, Massachusetts, USA). Immunoblotting was performed as in a previous study (Miao et al.,
2008), using primary antibodies, against collagen I/X (ab34710/ab58632, Abcam, Cambridge, UK),
collagen II (ab34712, Abcam, Cambridge, UK), Sirt1 (ab110304, Abcam, Cambridge, UK), superoxide
dismutase 1/2 (SOD1/2) (ab13498/ab13533, Abcam, Cambridge, UK), matrix metalloproteinases-13
(MMP-13) (ab52915/ab39012, Abcam, Cambridge, UK), nuclear factor kappa-B-p65 (NF-kB-p65)
(SC-71675, Santa Cruz, California, USA), insulin-like growth factor 1 (IGF-1) (ab9572, Abcam, Cam-
bridge, UK), vascular endothelial growth factor (VEGF) (ab69479, Abcam, Cambridge, UK), p19/53
(SC-1665/SC-126, Santa Cruz, California, USA), cyclin-dependent kinases 4/6 (CDK4/6) (ab199728/
ab131469, Abcam, Cambridge, UK), retinoblastoma protein/phosphorylated retinoblastoma protein
(Rb/pRB) (SC-74562/SC-56175, Santa Cruz, California, USA), transcription factor E2F1/2 (E2F1/2)
(SC-137059/SC-633, Santa Cruz, California, USA), and b-actin (ab8226, Abcam, Cambridge, UK).
Immunoreactive bands were analyzed by Scion Image Beta 4.02 and visualized with ECL (Beyotime,
Shanghai, China).
RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA was harvested from human NP cells and mouse disc tissues with TRIzol reagent (Beyo-
time, Shanghai, China). PrimeScript RT Master Mix (Perfect Real Time, TaKaRa, California, USA) was
used to reverse transcribe RNA to cDNA. Supplementary file 3 tabulates the qRT-PCR primer
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sequences. GAPDH was used for normalization. Relative mRNA expression levels were determined
by the 2 DDCt method.
Enzyme-linked immunosorbent assay (ELISA)
Serum samples were obtained from blood collected from the eyeballs of mice in each group. Mouse
NP cells were also collected by the method described above. The levels of IL-1b, IL-6 and TNF-a in
NP cell supernatants were determined using an ELISA kit (KeyGen, Nanjing, China).
Flow cytometry analyses
Total ROS production, NP cell proliferation and cell-cycle progression were separately assessed
using diacetyl dichlorofluorescein staining (Sigma Aldrich, Ohio, USA), propidium iodide staining
(KeyGen, Nanjing, China), and EdU Flow Cytometry Assay Kits (Invitrogen, Massachusetts, USA),
respectively. Human and mouse NP single-cell suspensions were prepared in PBS, and the cells were
treated with the corresponding specialized reagent. The cell pellets were incubated at 37˚C for 30
min and obtained by centrifugation. Finally, the specimens were investigated by flow cytometry with
a FACSCalibur flow cytometer.
CCK-8 cell viability assay
Cell proliferation was evaluated with a CCK-8 assay (KeyGen, Nanjing, China). In brief, cells in each
group (5000/well) were allowed to grow for 24, 48, and 72 hr. Ten microliters of CCK reagent in a
total volume of 100 ml was put into each well, before incubation for 3–4 hr. The absorbance at 450
nm was measured by an ELISA plate reader (Thermo Electron, Massachusetts, USA).
Chromatin immunoprecipitation (ChIP) assay
The 2000-bp region upstream of the p16 gene was selected as the promoter region according to
the National Center for Biotechnology Information database (http://www.ncbi.nlm.nih.gov/). After
predicting DNA-binding sites for the NF-kB-p65 transcription factor in the p16 promoter using the
JASPAR core database (Bryne et al., 2008), five putative binding sites were identified close to the
transcription start site. ChIP primers targeting these sites were designed by Primer Premier. ChIP
assays were carried out using a ChIP kit (CST, Massachusetts, USA) and a p65 antibody obtained
from Abcam. The relative binding of NF-kB-p65 to p16 was assessed by PCR, followed by digital
imaging of agarose gels.
Plasmid constructs and luciferase reporter gene assay
WT and mutant CDKN2A gene promoter segments were synthesized by Promoterbio Lab (Taizhou,
China) and then cloned into the pGL4.23-basic luciferase vector to obtain the pGL4.23-p16-wt and
pGL4.23-p16-mut plasmids: control plasmid (0.1 mg)+pGL4.23-basic vector (0.1 mg)+Renilla plasmid
(0.01 mg), control plasmid+pGL4.23-WT p16 promoter vector+Renilla plasmid, control plasmid
+pGL4.23-mutant p16 promoter vector+Renilla plasmid, NF-kB-p65 sequence plasmid+pGL4.23-ba-
asic vector+Renilla plasmid, NF-kB-p65 sequence plasmid+pGL4.23-WT p16 promoter vector
+Renilla plasmid, and NF-kB-p65 sequence plasmid+pGL4.23-mutant p16 promoter vector+Renilla
plasmid, separately with Lipofectamine2000 (Thermo Fisher, Massachusetts, USA). The cells were
incubated in normal culture medium for 48 hr after transfection. Luciferase assays was implemented
after the cells were collected and lysed. And then luciferase activity was standardized to Renilla lucif-
erase activity.
Statistical analyses
All analyses were carried out by SPSS software (version 20.0, USA). Mean ± SD was used to present
the data. To compare differences between groups, one-way ANOVA and student’s t-test were used.
After analysis using a chi-square test, qualitative data are presented as percentages. All graphs were
generated using GraphPad Software (version 5.0.0, USA). P values were two-sided, and p<0.05 indi-
cated statistical significance.
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Gonçalves AC, Cortesão E, Oliveiros B, Alves V, Espadana AI, Rito L, Magalhães E, Pereira S, Pereira A, Costa
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